Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

905 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RETRACTED: Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial.
Abd-Elsalam S, Salama M, Soliman S, Naguib AM, Ibrahim IS, Torky M, El Ghafar MSA, Abdul-Baki EAM, Elhendawy M. Abd-Elsalam S, et al. Among authors: salama m. Am J Trop Med Hyg. 2021 Sep 10;106(3):886-890. doi: 10.4269/ajtmh.21-0606. Am J Trop Med Hyg. 2021. Retraction in: Am J Trop Med Hyg. 2022 Sep 02:1. doi: 10.4269/ajtmh.1073ret. The above articles, published in The American Journal of Tropical Medicine and Hygiene, have been retracted by the Journal. The decision is the result of an investigation based on concerns raised by a third party. Specific concerns are as follows. First, a PMID: 34649223 Free PMC article. Retracted. Clinical Trial.
Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.
El-Bendary M, Abd-Elsalam S, Elbaz T, El-Akel W, Cordie A, Elhadidy T, Elalfy H, Farid K, Elegezy M, El-Badrawy A, Neamatallah M, Abd Elghafar M, Salama M, AbdAllah M, Essam M, El-Shazly M, Esmat G. El-Bendary M, et al. Among authors: salama m. Expert Rev Anti Infect Ther. 2022 Feb;20(2):291-295. doi: 10.1080/14787210.2021.1950532. Epub 2021 Jul 15. Expert Rev Anti Infect Ther. 2022. Retraction in: Expert Rev Anti Infect Ther. 2022 Sep;20(9):1243. doi: 10.1080/14787210.2022.2115244 PMID: 34225541 Retracted. Clinical Trial.
Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals.
Medhat MA, El-Kassas M, Karam-Allah H, Al Shafie A, Abd-Elsalam S, Moustafa E, Hassany SM, Salama M, Abd Elghafar MS, Sayed H, Badr M, Kamal DT, Shamseldeen A, Ossimi A, Moaz I, Esmael HE, Ezz Eldin AM, Ezzat S, Abdelghaffar H, Abdelghaffar K. Medhat MA, et al. Among authors: salama m. Arab J Gastroenterol. 2022 Aug;23(3):165-171. doi: 10.1016/j.ajg.2022.04.005. Epub 2022 May 6. Arab J Gastroenterol. 2022. PMID: 35690556 Free PMC article. Clinical Trial.
Epidemiology of liver cancer in Nile delta over a decade: A single-center study.
Abd-Elsalam S, Elwan N, Soliman H, Ziada D, Elkhalawany W, Salama M, Hawash N, Arafa M, Badawi R, Shehata WM, Khalil HS, Elmashad N. Abd-Elsalam S, et al. Among authors: salama m. South Asian J Cancer. 2018 Jan-Mar;7(1):24-26. doi: 10.4103/sajc.sajc_82_17. South Asian J Cancer. 2018. PMID: 29600229 Free PMC article.
Sofosbuvir-containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment.
Eletreby R, El-Serafy M, Anees M, Kasem G, Salama M, Elkhouly R, Hamdy M, Abdel Haleem H, Kamal E, Abdel-Razek W, Salama R, Elshenawy M, Shafeek A, Hassany M, El-Sayed MH, El-Shazly Y, Esmat G. Eletreby R, et al. Among authors: salama r, salama m. Liver Int. 2020 Apr;40(4):797-805. doi: 10.1111/liv.14299. Epub 2019 Dec 20. Liver Int. 2020. PMID: 31858694
905 results